Stay updated with breaking news from Johnson Medtech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A total hip replacement procedure available in Taunton and Yeovil has won a prestigious Health Service Journal Partnership Award.
/PRNewswire/ -- Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, today announced European CE mark...
Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, today announced European CE mark approval of the VARIPULSE™ Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation (AF) using pulsed field ablation (PFA). The VARIPULSE™ Platform is comprised...
J&J announces that Biosense Webster today announced the European CE Mark approval of the Varipulse platform for the treatment of symptomatic drug-refractory paroxysmal atrial fibrillation by pulsed...
Investigational device designed for Left Atrial Appendage Elimination (LAAX) to reduce the risk of stroke in patients with non-valvular atrial fibrillation